Search Results - Fang P
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP by Fang P, Ye Z, Li R, She D, Zong G, Zhang L, Xue Y, Zhang K
Published in Drug Design, Development and Therapy (2023-03-01)Get full text
Article -
5
-
6
-
7
A Bibliometric Analysis of Research on Natural Medicines for Depression from 2004 to 2024 by Lin L, Guo Z, Zhan Q, Fang P, Shi H, Feng Y, Tian S, Xiao L, Chen M, Wang T
Published in Journal of Multidisciplinary Healthcare (2025-10-01)Get full text
Article -
8
Restorative Effects of Daytime Naps on Inhibitory Control: A Neuroimaging Study Following Sleep Deprivation by Li L, Li Y, Yu S, Xu Z, Wang C, Guo F, Chang Y, Zhang R, Fang P, Zhu Y
Published in Nature and Science of Sleep (2025-03-01)Get full text
Article -
9
Identifying Metabolic Syndrome Easily and Cost Effectively Using Non-Invasive Methods with Machine Learning Models by Xu W, Zhang Z, Hu K, Fang P, Li R, Kong D, Xuan M, Yue Y, She D, Xue Y
Published in Diabetes, Metabolic Syndrome and Obesity (2023-07-01)Get full text
Article -
10
The Clinical Effect of Blue Light Therapy on Patients with Delayed Sleep-Wake Phase Disorder by Li D, Fang P, Liu H, Chen L, Fu Y, Liu J, Xie B, Liu Y, Ye H, Gu P
Published in Nature and Science of Sleep (2022-01-01)Get full text
Article -
11
Glucagon-Like Peptide 1 Receptor Agonist Improves Renal Tubular Damage in Mice with Diabetic Kidney Disease by Li R, She D, Ye Z, Fang P, Zong G, Zhao Y, Hu K, Zhang L, Lei S, Zhang K, Xue Y
Published in Diabetes, Metabolic Syndrome and Obesity (2022-04-01)Get full text
Article -
12
Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Patients with Overweight/Obesity by She D, Xu W, Liu J, Zhang Z, Fang P, Li R, Kong D, Xuan M, Liu Q, Pan MY, Wang Y, Xue Y
Published in Diabetes, Metabolic Syndrome and Obesity (2023-09-01)Get full text
Article -
13
